Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival

Autor: Leo J. Schouten, Marjolein H.F.M. Lentjes, Hubert J.M. Smeets, Matty P. Weijenberg, Piet A. van den Brandt, Colinda C. J. M. Simons, Ralph W.H. Gottschalk, A.M. Voets, Manon van Engeland, Frits H.M. van Osch
Přispěvatelé: Complexe Genetica, Genetica & Celbiologie, Epidemiologie, Gezondheidsrisico Analyse en Toxicologie, Pathologie, Klinische Genetica, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation, RS: CAPHRI - R5 - Optimising Patient Care, RS: GROW - Oncology, Psychiatrie & Neuropsychologie, RS: GROW - R1 - Prevention, RS: GROW - R2 - Basic and Translational Cancer Biology, RS: GROW - R4 - Reproductive and Perinatal Medicine, RS: FHML MaCSBio
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: Carcinogenesis, 36(12), 1502-1510. Oxford University Press
ISSN: 1460-2180
0143-3334
Popis: Low mitochondrial DNA (mtDNA) copy number in tumors has been associated with worse prognosis in colorectal cancer (CRC). This study further deciphers the role of mtDNA copy number in CRC by comparing mtDNA copy number between healthy, adenoma and carcinoma tissue, by investigating its association according to several clinicopathological characteristics in CRC, and by relating it to CRC-specific survival in CRC patients. A hospital-based series of samples including cancer, adenoma and adjacent histologically normal tissue from primary CRC patients (n = 56) and recurrent CRC (n = 16) was studied as well as colon mucosa samples from healthy subjects (n = 76). Furthermore, mtDNA copy number was assessed in carcinomas of 693 CRC cases identified from the population-based Netherlands Cohort Study (NLCS). MtDNA copy number was significantly lower in carcinoma tissue (P = 0.011) and adjacent tissue (P
Databáze: OpenAIRE